Market valued at $72.4M in 2024, projected 7.30% CAGR growth driven by pharmaceutical API synthesis, food-grade ...
Dublin, Jan. 08, 2025 (GLOBE NEWSWIRE) -- The "High Potency API Contract Manufacturing Market by Product, Synthesis, Application, Dosage Form, End User and Region" report has been added to ...
AUSTIN, Texas and TOKYO, Oct. 3, 2025 /PRNewswire/ -- According to DataM Intelligence, the Active Pharmaceutical Ingredients Market Size reached US$ 238.7 Billion in 2024, up from US$ 224.7 Billion in ...
BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma, a leading provider of tailored API and CDMO services for the full drug product life cycle, today reported that its unique mix of active pharmaceutical ...
Aoxing Pharmaceutical (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, ...
BEDMINSTER, N.J. and DUBLIN, Ireland, Aug 26, 2013 (GLOBE NEWSWIRE via COMTEX) -- Amarin Corporation plc AMRN +4.29% , a biopharmaceutical company focused on the commercialization and development of ...
MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients. Following the MHRA decision, pharma& expects that ...
Shardul Nautiyal, Mumbai Friday, January 2, 2026, 08:00 Hrs [IST] ...
Rising chronic diseases, biologics use, cancer cases, and advanced drug R&D are driving global API market growth and drug demand across regions. HYDERABAD, TELANGANA, INDIA, May 26, 2025 /EINPresswire ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback